| Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure? | |
MedLine Citation:
|
PMID: 21962427 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Heart failure (HF) and benign prostatic hypertrophy (BPH) are two conditions that commonly coexist in men 60 years and older. Carvedilol is the only β-adrenergic blocker approved for HF that also has additional α1-adrenergic blockade. As α1-adrenergic blockers are used in the treatment of BPH, it is intuitive that carvediolol could improve BPH symptoms. We present a case where carvedilol was replaced with bisoprolol resulting in acute urinary retention. When carvediolol was reinstituted, the patient's symptoms of BPH resolved. Benign prostatic hypertrophy was later diagnosed by digital rectal exam. Six month after reinstituting the carvediolol, the patient remains free of his BPH symptoms. This case suggests that carvedilol may be considered for the management of HF with systolic dysfunction in patients with concomitant BPH thus eliminating the need for an α1-adrenergic blockers. |
Authors:
|
Colleen K Rohrer; Robert Lee Page; Simon F Shakar; Joann Lindenfeld |
Related Documents
:
|
3471367 - Clinical pharmacology of oral and intravenous 4-demethoxydaunorubicin. 16611657 - Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonar... 17404847 - Combination therapy in liver transplant recipients with hepatitis b virus without hepat... 12140037 - Treatment of conjunctival papillomata with topical interferon alfa-2b. 17825587 - Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoart... 2412037 - Double-blind comparison of ketanserin with propranolol in hypertensive patients: interi... |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2011-06-23 |
Journal Detail:
|
Title: Journal of cardiac failure Volume: 17 ISSN: 1532-8414 ISO Abbreviation: J. Card. Fail. Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-03 Completed Date: 2012-01-17 Revised Date: 2013-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 9442138 Medline TA: J Card Fail Country: United States |
Other Details:
|
Languages: eng Pagination: 875-7 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Elsevier Inc. All rights reserved. |
Affiliation:
|
Division of Cardiology, Department of Medicine, School of Medicine, University of Colorado, Aurora, Colorado, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
administration & dosage,
adverse effects,
therapeutic use* Aged Bisoprolol / adverse effects* Carbazoles / administration & dosage, therapeutic use* Heart Failure / complications, drug therapy*, pathology Humans Male Propanolamines / administration & dosage, therapeutic use* Prostatic Hyperplasia / complications, drug therapy*, pathology Urinary Retention / chemically induced |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 0K47UL67F2/carvedilol; 66722-44-9/Bisoprolol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Molecular signatures of end-stage heart failure.
Next Document: Reactivity of Activated versus Non-activated 2-(Bromomethyl)aziridines with respect to Sodium Methox...